Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 215

    1.

    Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.

    Martinez-Picado J, Negredo E, Ruiz L, Shintani A, Fumaz CR, Zala C, Domingo P, Vilaró J, Llibre JM, Viciana P, Hertogs K, Boucher C, D'Aquila RT, Clotet B; SWATCH Study Team.

    Ann Intern Med. 2003 Jul 15;139(2):81-9.PMID: 12859157 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.

    Negredo E, Paredes R, Peraire J, Pedrol E, Côté H, Gel S, Fumoz CR, Ruiz L, Abril V, Rodriguez de Castro E, Ochoa C, Martinez-Picado J, Montaner J, Rey-Joly C, Clotet B; Swatch Study Team.

    Antivir Ther. 2004 Dec;9(6):889-93.PMID: 15651747 [PubMed - indexed for MEDLINE]Related articles

    3.

    Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Gulick RM, Ribaudo HJ, Shikuma CM, Lalama C, Schackman BR, Meyer WA 3rd, Acosta EP, Schouten J, Squires KE, Pilcher CD, Murphy RL, Koletar SL, Carlson M, Reichman RC, Bastow B, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team.

    JAMA. 2006 Aug 16;296(7):769-81.PMID: 16905783 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.

    Swindells S, DiRienzo AG, Wilkin T, Fletcher CV, Margolis DM, Thal GD, Godfrey C, Bastow B, Ray MG, Wang H, Coombs RW, McKinnon J, Mellors JW; AIDS Clinical Trials Group 5201 Study Team.

    JAMA. 2006 Aug 16;296(7):806-14.PMID: 16905786 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

    Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.PMID: 12617573 [PubMed - indexed for MEDLINE]Related articles

    6.

    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

    MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.PMID: 12027060 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal.

    Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group.

    MedGenMed. 2007 Oct 9;9(4):7.PMID: 18311357 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Summaries for patients. Alternating drug regimens to treat HIV infection.

    [No authors listed]

    Ann Intern Med. 2003 Jul 15;139(2):I16. No abstract available. PMID: 12859174 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

    Aboulker JP, Babiker A, Chaix ML, Compagnucci A, Darbyshire J, Debré M, Faye A, Giaquinto C, Gibb DM, Harper L, Saïdi Y, Walker AS; Paediatric European Network for Treatment of AIDS.

    AIDS. 2004 Jan 23;18(2):237-45.PMID: 15075541 [PubMed - indexed for MEDLINE]Related articles

    10.

    Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.

    Foli A, Maserati R, Barasolo G, Castelli F, Tomasoni L, Migliorino M, Maggiolo F, Pan A, Paolucci S, Scudeller L, Tinelli C, D'Aquila R, Lisziewicz J, Lori F.

    Antivir Ther. 2004 Feb;9(1):123-32.PMID: 15040544 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.

    Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dubé MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS; AIDS Clinical Trials Group 384 Team.

    N Engl J Med. 2003 Dec 11;349(24):2293-303.PMID: 14668455 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

    Rutherford GW, Sangani PR, Kennedy GE.

    Cochrane Database Syst Rev. 2003;(4):CD002037. Review.PMID: 14583945 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.

    Sánchez-Conde M, Palacios R, Sanz J, Rodríguez-Novoa S, Rivas P, Santos J, Sola J, Asensi V, de Mendoza C, Estrada V, Barreiro P, González-Lahoz J, Jiménez-Nacher I, Soriano V.

    AIDS Res Hum Retroviruses. 2007 Oct;23(10):1237-41.PMID: 17961110 [PubMed - indexed for MEDLINE]Related articles

    14.

    Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.

    DeJesus E, McCarty D, Farthing CF, Shortino DD, Grinsztejn B, Thomas DA, Schrader SR, Castillo SA, Sension MG, Gough K, Madison SJ; EPV20001 International Study Team.

    Clin Infect Dis. 2004 Aug 1;39(3):411-8. Epub 2004 Jul 15.PMID: 15307010 [PubMed - indexed for MEDLINE]Related articles

    15.

    Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.

    Scherpbier HJ, Bekker V, Pajkrt D, Jurriaans S, Lange JM, Kuijpers TW.

    Pediatrics. 2007 Mar;119(3):e705-15. Epub 2007 Feb 16.PMID: 17308244 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.

    Gulick RM, Lalama CM, Ribaudo HJ, Shikuma CM, Schackman BR, Schouten J, Squires KE, Koletar SL, Pilcher CD, Reichman RC, Klingman KL, Kuritzkes DR.

    AIDS. 2007 Apr 23;21(7):813-23.PMID: 17415036 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

    Ruiz L, Paredes R, Gómez G, Romeu J, Domingo P, Pérez-Alvarez N, Tambussi G, Llibre JM, Martínez-Picado J, Vidal F, Fumaz CR, Clotet B; TIBET Study Group.

    AIDS. 2007 Jan 11;21(2):169-78.PMID: 17197807 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.

    [No authors listed]

    Prescrire Int. 2004 Aug;13(72):144-50.PMID: 15532140 [PubMed - indexed for MEDLINE]Related articles

    19.

    A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.

    Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO.

    West Afr J Med. 2002 Apr-Jun;21(2):83-6.PMID: 12403023 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.

    Ribera E, Rodríguez-Pardo D, Rubio M, Soler A, Pedrol E, Blanco JL, González A, Crespo M, Falcó V, Ocaña I, Deig E, Miró JM, Pahissa A.

    Antivir Ther. 2005;10(5):605-14.PMID: 16152754 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data